Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alternative splicing in lung cancer.
Coomer AO, Black F, Greystoke A, Munkley J, Elliott DJ. Coomer AO, et al. Among authors: greystoke a. Biochim Biophys Acta Gene Regul Mech. 2019 Nov-Dec;1862(11-12):194388. doi: 10.1016/j.bbagrm.2019.05.006. Epub 2019 May 29. Biochim Biophys Acta Gene Regul Mech. 2019. PMID: 31152916 Review.
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors.
Bashir B, Wang JS, Falchook G, Fontana E, Arkenau HT, Carter L, Galot R, Basu B, Greystoke A, Subbiah V, Richardson DL, Orr H, Bennett G, Sharma R, Xu H, Paganoni P, Xu C, Campbell C, McKean M. Bashir B, et al. Among authors: greystoke a. J Clin Oncol. 2024 Oct 10;42(29):3443-3452. doi: 10.1200/JCO.23.01107. Epub 2024 Sep 4. J Clin Oncol. 2024. PMID: 39231383 Clinical Trial.
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis.
Messina C, Giunta EF, Signori A, Rebuzzi SE, Banna GL, Maniam A, Buti S, Cattrini C, Fornarini G, Bauckneht M, Greystoke A, Plummer R, Oing C, Rescigno P. Messina C, et al. Among authors: greystoke a. Eur Urol Oncol. 2024 Apr;7(2):179-188. doi: 10.1016/j.euo.2023.07.013. Epub 2023 Aug 12. Eur Urol Oncol. 2024. PMID: 37574390 Free article. Review.
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors.
Juric D, Barve M, Vaishampayan U, Roda D, Calvo A, Jañez NM, Trigo J, Greystoke A, Harvey RD, Olszanski AJ, Opyrchal M, Spira A, Thistlethwaite F, Jiménez B, Sappal JH, Kannan K, Riley J, Li C, Li C, Gregory RC, Miao H, Wang S. Juric D, et al. Among authors: greystoke a. Cancer Med. 2024 Mar;13(5):10.1002/cam4.6776. doi: 10.1002/cam4.6776. Cancer Med. 2024. PMID: 38501219 Free PMC article. Clinical Trial.
Social determinants of health inequalities in early phase clinical trials in Northern England.
Rae S, Shaya S, Taylor E, Hoben J, Oluwashegun D, Lowe H, Haris N, Bashir S, Oing C, Krebs MG, Thistlethwaite FC, Carter L, Cook N, Greystoke A, Graham DM, Plummer R. Rae S, et al. Among authors: greystoke a. Br J Cancer. 2024 Sep;131(4):685-691. doi: 10.1038/s41416-024-02765-w. Epub 2024 Jun 24. Br J Cancer. 2024. PMID: 38914804 Free PMC article.
Hypofractionated Concomitant Chemoradiation in Inoperable Locally Advanced Non-small Cell Lung Cancer: A Report on 100 Patients and a Systematic Review.
Iqbal MS, Vashisht G, McMenemin R, Atherton P, McDonald F, Simmons T, Bradshaw A, Kovarik J, Turnbull H, Dodd L, Mulvenna P, Greystoke A. Iqbal MS, et al. Among authors: greystoke a. Clin Oncol (R Coll Radiol). 2019 Feb;31(2):e1-e10. doi: 10.1016/j.clon.2018.10.006. Epub 2018 Nov 8. Clin Oncol (R Coll Radiol). 2019. PMID: 30415784
110 results